9/14/2011

Patients using tumor necrosis factor inhibitors to treat rheumatoid arthritis appear to be at higher risk
of skin cancer, including melanoma, than those who don't use the drugs, according to a systematic review and meta-analysis in the Annals of the Rheumatic Diseases. However, TNF blockers do not seem to increase the risk of other cancer types, particularly lymphoma, researchers said.

Full Story:
Nurse.com

Related Summaries